Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders

Frits W. Prinzen, Nikolaos Dagres, Andreas Bollmann, David O. Arnar, Sylvie Bove, John Camm, Barbara Casadei, Paulus Kirchhof, Karl-Heinz Kuck, Joost Lumens, Martin C. Michel, Peter J. Schwartz, Betty Van Vleymen, Panos Vardas, Gerhard Hindricks

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)733-738
Number of pages6
JournalEP Europace
Volume20
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Innovation
  • Electrophysiology
  • Arrhythmias
  • Devices
  • Genetics
  • Computer models
  • Big Data
  • Personalized medicine
  • Basic science
  • Patents
  • Clinical trial
  • Reimbursement

Cite this

Prinzen, F. W., Dagres, N., Bollmann, A., Arnar, D. O., Bove, S., Camm, J., Casadei, B., Kirchhof, P., Kuck, K-H., Lumens, J., Michel, M. C., Schwartz, P. J., Van Vleymen, B., Vardas, P., & Hindricks, G. (2018). Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders. EP Europace, 20(5), 733-738. https://doi.org/10.1093/europace/eux095